Guy Reed, MD, began more than a decade ago to research a safer, more effective therapy for dissolving blood clots, which are the cause of most strokes. The outcome of that research is a novel thrombus (blood clot) dissolving agent, TS23, which is currently undergoing clinical trials. For his groundbreaking effort, Dr. Reed, the Lemuel Diggs Professor… Read More
The Mobile Stroke Unit in Memphis, where stroke incidence is 37 percent higher than the national average, is the first launched in the high-incidence Southeastern United States “Stroke Belt” The University of Tennessee College of Medicine in Memphis, Tenn., today introduced the world’s most comprehensive Mobile Stroke Unit, capable of conducting and producing advanced quality… Read More
When researchers released the findings of a national blood pressure study showing that aggressive intervention to lower systolic blood pressure in older adults below conventional standards reduces cardiovascular disease, stroke and death, it wasn’t news to Memphis landscape company owner Joe Pipkin. A five-year participant in the Memphis site of the landmark Systolic Blood Pressure… Read More
